ReviewDrug design, development and therapy2026

Advances in PARP Inhibition in Improving Outcomes of Breast Cancer, Ovarian Cancer, and Other Solid Tumors: Journey of Discovery, Development, and Clinical Updates of Talazoparib.

Muhammad Latif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.